Skip to main content

Walbert Timothy P's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Oct 1, 2021

Accession no.
0001209191-21-058424
Filed
Oct 1, 2021
Trade date
Sep 17-30, 2021
Filing delay
14 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.52M. It was filed 14 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walbert Timothy PCIK 0001349376Director, Officer (Chairman, President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 17, 2021Ordinary SharesGGiftDisposed−107,739$0.00$0739,984Direct
Sep 17, 2021Ordinary SharesGGiftAcquired+107,739$0.00$0107,739Indirect
Sep 17, 2021Ordinary SharesGGiftDisposed−110,502$0.00$0629,482Direct
Sep 17, 2021Ordinary SharesGGiftAcquired+110,502$0.00$0131,496Indirect
Sep 30, 2021Ordinary SharesSSaleDisposed−30,460$109.96−$3,349,381.6599,022Direct
Sep 30, 2021Ordinary SharesSSaleDisposed−18,940$110.80−$2,098,552580,082Direct
Sep 30, 2021Ordinary SharesSSaleDisposed−600$112.01−$67,206579,482Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)